Postpartum Hemorrhage After Operative Vaginal Delivery
31-year-old G2P1 at 39+4 weeks is induced for gestational hypertension. After a prolonged second stage, a vacuum-assisted vaginal delivery is performed for a 3.9 kg infant; a mediolateral episiotomy is repaired and the placenta appears complete. Estimated blood loss at delivery is 900 mL, and a continuous trickle continues. Thirty minutes later she is alert, HR 118/min, BP 104/66 mmHg, RR 22/min, SpO2 98% on room air. The uterine fundus is boggy at the umbilicus; fundal massage expresses clots, and the bladder is distended. An 18-gauge IV line is in place, oxytocin 10 units IM has been given, and 1 L crystalloid has infused. Point-of-care hemoglobin is 88 g/L, platelets 210 × 10^9/L, INR 1.1, fibrinogen 2.4 g/L. The obstetrician is 10 minutes away; the operating room is available, and a blood bank is on site.
1. What is the leading physiologic diagnosis, and what immediate actions should be taken in the first 15 minutes? Explain how each action addresses the underlying problem.
Read the worked answer
The leading diagnosis is uterine atony, but after an operative vaginal delivery the ongoing trickle also requires parallel exclusion of genital tract trauma and retained placental fragments. The shock index (HR 118 ÷ systolic BP 104 ≈ 1.13) is abnormal even though BP is not yet low, suggesting compensated hypovolemia. Immediate actions: call for help and formally quantify blood loss; place a second large-bore IV; send CBC, coagulation studies, fibrinogen, and type-and-crossmatch; empty the bladder because distension impairs uterine contraction; perform fundal massage and bimanual uterine compression; start a dilute oxytocin infusion after the loading dose; give tranexamic acid 1 g IV within 3 hours of birth; inspect the perineum, vagina, and cervix under good light; and prepare the operating room while continuing resuscitation. Recheck vital signs every 5–10 minutes. If bleeding does not slow with these measures, the next step is examination under anesthesia and uterine evacuation, not repeated blind massage.
2. Which uterotonic agents are appropriate given her gestational hypertension, and which should be avoided? Justify your choices.
Read the worked answer
Oxytocin remains first-line and can be continued as an infusion because it does not cause clinically important vasoconstriction at standard doses. Methylergonovine should be avoided: it is an ergot alkaloid with alpha-adrenergic vasoconstrictor activity and can cause severe hypertension, coronary vasospasm, and stroke, especially in a patient with gestational hypertension. Carboprost, a prostaglandin F2-alpha analogue, is second-line but must be used cautiously because it can cause bronchospasm; it is contraindicated in asthma. Misoprostol, a prostaglandin E1 analogue, is a reasonable second-line agent and can be given sublingually or rectally; it commonly causes pyrexia and shivering but lacks the hypertensive risk of ergots. Tranexamic acid is not a uterotonic but should be given early because it reduces fibrinolysis and mortality from postpartum hemorrhage. The choice therefore balances uterine efficacy against this patient's hypertensive profile, and methylergonovine is the key agent to exclude.
3. After 20 minutes of uterotonics and bimanual compression, bleeding persists and she becomes tachycardic at 130/min with BP 92/58 mmHg. What is the decision threshold for transfer to the operating room, and what surgical and transfusion steps should be prepared?
Read the worked answer
This is now ongoing major postpartum hemorrhage with maternal instability: persistent bleeding after appropriate uterotonics, a rising shock index, and hypotension define failure of medical management. Transfer to the operating room should not wait for a specific hemoglobin value. Prepare for examination under anesthesia to identify lacerations and retained tissue, uterine evacuation, and laparotomy if bleeding continues. Alert the blood bank and activate the massive transfusion protocol; give packed red cells, plasma, and platelets in a balanced ratio, and check fibrinogen because fibrinogen below 2 g/L predicts severe hemorrhage. Consider intrauterine balloon tamponade or vacuum-induced tamponade while moving to the operating room, and involve interventional radiology for uterine artery embolization if available. Uterotonic infusion and tranexamic acid continue. Consent for hysterectomy should be obtained because it is the definitive life-saving step if uterine-sparing measures fail. The team should designate a leader and a scribe.